State-of-the-Art Virology Research in Canada
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "General Virology".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 33089
Special Issue Editor
Interests: cellular restriction factors; antiviral proteins; HIV; Ebola; SARS-CoV-2; innate immunity; retroviral integration; HERC5; ISG15; viral antagonists; virus–host interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viruses are submicroscopic entities that can have a profound impact on many life forms. Understanding how viruses replicate and cause disease is critical for the development of novel antiviral therapeutics and control measures. Canadian researchers have contributed numerous important advancements in the development of tools and methods to better understand virus biology and the progression of virus-induced diseases, imaging of viruses in vitro and in vivo, mechanisms of viral pathogenesis, host immune responses against viruses, viral immune evasion, identification of novel antiviral agents, development of diagnostic reagents to characterize hidden reservoirs of viruses and for the early and accurate detection of viral infections, and in understanding how viruses jump the species barrier. This Special Issue highlights state-of-the-art virology research in Canada. We welcome submissions from Canadian institutions of original research articles and comprehensive reviews including—but not limited to—the above-mentioned areas.
Dr. Stephen Barr
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Canada
- state-of-the-art
- virus-host interactions
- virus biology
- progression of virus-induced diseases
- imaging of viruses
- viral pathogenesis
- viral immune evasion
- antiviral responses
- antiviral agents
- diagnostic reagents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.